Optima Capital’s Guardant Health GH Stock Holding History

Optima Capital’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5	Closed	-$511	–	608
2025 Q4	$511	Buy	+5	New	+$447	﹤0.01%	1218

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Optima Capital's GH Position: Q1 2026 in Review

Optima Capital sold out of Guardant Health (GH) in Q1 2026, closing a stake of 5 shares — an estimated $511 sold.

Optima Capital first reported a position in GH in Q4 2025 and held it in 1 quarter. The position peaked at $511 in Q4 2025. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Optima Capital reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
Optima Capital sold 5 Guardant Health shares in Q1 2026, an estimated $511.
Optima Capital first reported a position in Guardant Health in Q4 2025 and held it in 1 quarter.
Optima Capital's Guardant Health position peaked at $511 in Q4 2025.
482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Optima Capital's 13F filing for Q1 2026, filed 5 May 2026.